从复审和无效案例反思药物晶型专利的创造性审查
Assessment of Inventive Step of Polymorphic Drug Patent from the Perspective of Patent Reexamination and Invalidation
柴伟 1高文婷1
作者信息
- 1. 国家知识产权局专利局专利审查协作江苏中心,江苏 苏州 215163
- 折叠
摘要
文章通过梳理若干涉及药物衍生物晶型的复审和无效案例,探讨了创造性审查中最接近对比文件的选择、技术效果的确定,并结合具体案例展开分析,以期为药物衍生物晶型的专利审查提供可行性建议,从而提高专利的审查质量和授权后的稳定性.
Abstract
By combing through several review processes involving patent reexamination and invalidation,this article discussed how to choose the closest prior art and the determination of technical effect,and in combination with typical cases,it is expected to provide feasible suggestions for patent examination of crystal forms of drug derivatives,thereby improving patent examination quality and stability after authorization.
关键词
衍生物/药物/晶型/创造性/审查Key words
drug derivatives/polymorphic drug/inventive step/patent examination引用本文复制引用
出版年
2024
NETL
NSTL
万方数据